The following table shows the list of clinical trials and studies included in Dataset Explorer. Items underlined and in red are either new or updated in this release.
Note: You may see the notations NA and Unknown in the trial and study data. NA indicates not applicable, and Unknown indicates not available.
|
Trial Name study |
Area of Study |
RBM |
ELISA |
Proteomics |
mRNA |
Cell-Based Markers |
Metabolomics |
|
Other | |||||
|
26866138_CAN-1001_ |
An Open-Label Study to Assess the Effect of Omeprazole Administration on the Pharmacokinetics of VELCADE in Subjects With Advanced SolidTumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma |
|
|
|
|
|
|
✓ |
|
| ||||
|
26866138_LYM-3001_ |
A randomized, open-label, multicenter study of VELCADE with Rituximab or Rituximab alone in subjects with relapsed or refractory, Rituximab naïve or sensitive follicular B-cell Non-Hodgkin’s Lymphoma |
|
|
✓ |
|
|
|
✓ |
|
| ||||
|
26866138_MMY-3002_ |
An Open-Label, Randomized Study of VELCADE/ Melphalan/Prednisone Versus Melphalan/Prednisone in Subjects With Previously Untreated Multiple Myeloma |
|
|
|
|
|
|
✓ |
|
| ||||
|
38518168_ |
A Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of JNJ-38518168 in Subjects with Active Rheumatoid Arthritis Despite Methotrexate Therapy With Synovial Biopsy Substudy |
|
|
|
|
|
|
|
|
| ||||
|
39758979_ |
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Exploratory Study of the Safety and Efficacy of JNJ-39758979 in the Treatment of Adults with Persistent Asthma |
|
|
|
|
|
|
|
|
| ||||
|
C-2006-004_ |
A Double-blind, Randomized, Placebo-Controlled, Sequential Cohort Exploratory Study of the Safety and Efficacy of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis that is Moderate in Severity |
|
|
|
|
✓ |
|
|
|
| ||||
|
C-2006-009_ |
A Phase IIa Multicenter, Randomized, Double-Blind, Placebo -Controlled, Parallel Group Study of RWJ-445380 Cathepsin-S Inhibitor in Subjects with Active Rheumatoid Arthritis Despite Methotrexate Therapy |
✓ |
✓ |
|
|
|
|
|
|
| ||||
|
C0168T29_ |
A Randomized, Double-blind, Trial of Anti-TNF Chimeric Monoclonal Antibody (Infliximab) in Combination with Methotrexate Compared with Methotrexate Alone for the Treatment of Patients with Early Rheumatoid Arthritis |
|
✓ |
|
|
|
|
|
|
| ||||
|
C0168T30_ |
A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled Pilot Trial Evaluating the Effects of Infliximab (REMICADE®) in Patients with Stable Class III or IV Congestive Heart Failure |
|
|
|
|
|
|
|
|
| ||||
|
C0168T32_ |
A Randomized, Double-blind Trial of Anti-TNF Chimeric Monoclonal Antibody (Infliximab) in Combination with Methotrexate for the Treatment of Patients with Polyarticular Juvenile Rheumatoid Arthritis |
|
✓ |
|
|
|
|
|
|
| ||||
|
C0168T37_ |
A Randomized, Placebo-controlled, Double-blind Trial to Evaluate the Safety and Efficacy of Infliximab in Patients with Active Ulcerative Colitis |
|
✓ |
|
|
|
|
|
|
| ||||
|
C0168T37_ |
A Randomized, Placebo-controlled, Double-blind Trial to Evaluate the Safety and Efficacy of Infliximab in Patients with Active Ulcerative Colitis |
✓ |
|
|
|
|
|
|
|
| ||||
|
C0168T41_ |
A Randomized, Double-blind Trial of the Safety of Anti-TNF Chimeric Monoclonal Antibody (Infliximab) in Combination with Methotrexate Compared to Methotrexate Alone in Patients with Rheumatoid Arthritis on Standard Disease-modifying Antirheumatic Drug Background Therapy |
|
|
|
|
|
|
|
|
| ||||
|
C0168T44_ |
A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of Infliximab Induction Therapy Followed by Multiple Regimens of Maintenance Infliximab Therapy in Subjects with Plaque-type Psoriasis |
|
|
|
✓ |
|
|
|
|
| ||||
|
C0168T48_ |
A Multicenter, Randomized, Double-blind, Placebo controlled Trial Evaluating the Safety and Efficacy of Infliximab (REMICADE®) in Subjects with Chronic Sarcoidosis with Pulmonary Involvement |
✓ |
✓ |
|
|
|
|
|
|
| ||||
|
C0168T50_ |
A Multicenter, Randomized, Double-blind Trial of Anti-TNF Chimeric Monoclonal Antibody (Infliximab) for the Treatment of Subjects with Psoriatic Arthritis |
|
✓ |
|
|
|
|
|
|
| ||||
|
C0168T54_ |
A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled Parallel Group, Dose Finding Study Evaluating the Safety and Efficacy of Infliximab Administration in Symptomatic Subjects with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) |
✓ |
✓ |
|
|
✓ |
|
|
|
| ||||
|
C0168T60_ |
A Phase II, Multicenter, Randomized, Double-blind, Placebo controlled Study Evaluating the Efficacy and Safety of Anti-TNF Monoclonal Antibody (Infliximab) to Treat Cancer-Related Cachexia in Subjects with Pancreatic Cancer |
|
|
|
|
|
|
|
|
| ||||
|
C0168T65_ |
A Randomized, Double-masked, Placebo-controlled, Multicenter Study of the Safety and Efficacy of Infliximab in Subjects with Giant Cell Arteritis |
|
|
|
|
|
|
|
|
| ||||
|
C0328T05_ |
A Phase 2 Multicenter Study of Siltuximab (Anti IL-6 Monoclonal Antibody) in Subjects with Relapsed or Refractory Multiple Myeloma |
✓ |
✓ |
|
✓ |
|
|
|
|
| ||||
|
C0524T02_ |
A Randomized, Double-blind, Dose-ranging Trial of CNTO 148 Subcutaneous Injection Compared with Placebo in Subjects With Active Rheumatoid Arthritis Despite Treatment With Methotrexate |
|
✓ |
|
|
|
|
|
|
| ||||
|
C0524T03_ |
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety Of CNTO 148 Administered Subcutaneously in Symptomatic Subjects With Severe Persistent Asthma |
✓ |
✓ |
|
✓ |
|
|
✓ |
|
| ||||
|
C0524T05_ |
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously, in Methotrexate-naïve Subjects with Active Rheumatoid Arthritis |
✓ |
✓ |
|
|
|
|
|
|
| ||||
|
C0524T06_ |
A Study of the Safety and Efficacy of Golimumab in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
✓ |
✓ |
|
|
✓ |
|
|
|
| ||||
|
C0743T10_ |
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of CNTO 1275, a Fully Human Anti-IL-12 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Psoriatic Arthritis |
✓ |
✓ |
|
|
|
|
|
|
| ||||
|
C1034T02_ |
A Phase 1/2, Multi-Center, Blinded, Randomized, Controlled Study of the Safety and Efficacy of the Human Monoclonal Antibody to Human Integrins (CNTO 95), Alone and in Combination with Dacarbazine, in Subjects with Stage IV Melanoma |
|
|
|
|
|
|
|
|
| ||||
|
C1034T06_ |
A Phase 1, Multi-Center, Open-Label, Ascending-Dose Study of the Safety of the Human Monoclonal Antibody to Human ?V Integrins (CNTO 95) in Combination with Docetaxel in Subjects with Metastatic Hormone Refractory Prostate Cancer |
|
|
|
|
|
|
|
|
| ||||
|
C1034T07_ |
A Phase 1, Multicenter, Open-label, Multiple-administration Study of CNTO 95, a Human Monoclonal Antibody to the Human Alpha v Integrin Receptors, in Patients with Melanoma or Angiosarcoma |
|
✓ |
|
|
✓ |
|
|
|
| ||||
|
C1034T08_ |
A Randomized, Double-blind, Multicenter, Phase 2 Study of a Human Monoclonal Antibody to Human v Integrins (CNTO 95) in Combination With Docetaxel and Prednisone for the First-Line Treatment of Subjects With Metastatic Hormone Refractory Prostate Cancer |
|
|
|
|
|
|
|
|
| ||||
Experimental Medicine Studies
|
Experimental Medicine Study Name |
Area of Study |
Compound |
RBM |
ELISA |
Proteomics |
mRNA |
Cell-Based Markers |
Metabolomics |
|
Other | |||||
|
ADNI |
Alzheimer’s Disease Neuroimaging Initiative (ADNI) – Multi-center, non-treatment study |
N/A |
|
|
|
|
|
|
✓ |
|
| ||||
|
BRC Anti-depressant Study |
Depression |
Various anti-depressants |
|
|
✓ |
✓ |
|
✓ |
✓ |
✓ |
✓ | ||||
|
BRC
Depression Study_ |
Depression |
n/a |
|
|
✓ |
✓ |
|
✓ |
✓ |
✓ |
✓ | ||||
|
C0328X02_ |
Prostate Adenocarcinoma |
Siltuximab |
|
✓ |
✓ |
✓ |
|
|
|
|
| ||||
|
C0743X01_ See the note following table |
Detection of Mediators of Sarcoidosis Skin Lesions. |
n/a |
✓ |
|
|
✓ |
|
|
|
|
| ||||
|
NORMALS |
n/a |
n/a |
✓ |
|
|
|
|
|
|
|
| ||||
|
Sebastian
Johnston_ |
Discovery of novel therapies for asthma exacerbations. |
n/a |
✓ |
|
|
✓ |
|
|
|
|
| ||||
Note: Experiment C0743X01 contains sets of gene expression data based on skin tissue samples and blood samples. Performing a comparison of gene expression data based on different types of samples will yield scientifically invalid results.
Internal Studies
|
Internal Study Name |
Area of Study |
RBM |
ELISA |
Proteomics |
mRNA |
Cell-Based Markers |
Metabolomics |
|
Other | |||||
|
A431CellLineSCC_ |
Effect of CNTO2559 anti-Tissue Factor Antibody on A431 Human Squamous Cell Carcenoma Xenografts in Female SCID Beige Mice |
|
|
|
✓ |
|
|
|
|
| ||||
|
A431CellLineSCC_ |
Effect of CNTO6141 anti-Tissue Factor Antibody on A431 Human Squamous Cell Carcenoma Xenografts in Female SCID Beige Mice |
✓ |
|
|
✓ |
|
|
|
|
| ||||
|
Precos_Colorectal |
Colorectal tissue: study mode of action of two drugs and identify pharmacodynamic and response predictive markers. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Precos_Gastric |
Gastric tissue: study mode of action of two drugs and identify pharmacodynamic and response predictive markers. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Precos_Metastatic |
Study based on liver tissue. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Precos_Oesophageal |
Oesophageal tissue: study mode of action of two drugs and identify pharmacodynamic and response predictive markers. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Precos_Pancreatic |
Pancreatic tissue: study mode of action of two drugs and identify pharmacodynamic and response predictive markers. |
|
|
|
✓ |
|
|
|
|
| ||||
|
TNBC2010_Triple_ |
A study of breast tissue samples obtained from an outside vendor (Asterand). |
|
|
|
|
|
|
|
|
| ||||
|
Veridex_Breast |
Find marker genes for human breast cancer. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Veridex_Colon |
Find marker genes for human colon cancer. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Veridex_Lung |
Find marker genes for human lung cancer. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Veridex_Ovary |
Find marker genes for human ovary cancer. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Veridex_Prostate |
Find marker genes for human prostate cancer. |
|
|
|
✓ |
|
|
|
|
| ||||
Public Studies
|
Public Study Name |
Area of Study |
RBM |
ELISA |
Proteomics |
mRNA |
Cell-Based Markers |
Metabolomics |
|
Other | |||||
|
Ambs_Prostate |
Tumor immunobiological differences in prostate cancer between African-American and European-American men. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Ammous_COPD_ |
Variability in Small Airway Epithelial Gene Expression Among Normal Smokers |
|
|
|
✓ |
|
|
|
|
| ||||
|
Arijs_IBD_ |
Mucosal expression profiling in patients with inflammatory bowel disease. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Beer_Lung |
Gene-expression profiles predict survival of patients with lung adenocarcinoma |
|
|
|
✓ |
|
|
|
|
| ||||
|
Bhattacharjee_Lung |
Classification of human lung carcinomas by mRNA expression profiling. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Bienkowska_ |
Whole blood transcript profiling of rheumatoid arthritis patients. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Bochkov_Asthma_ |
Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma |
|
|
|
✓ |
|
|
|
|
| ||||
|
Bosco_Asthma_ |
Expression in induced sputum during acute exacerbations in asthmatic children with/without chronic airflow obstruction |
|
|
|
✓ |
|
|
|
|
| ||||
|
Carolan_COPD_ |
Airway epithelium, small airways, normal non-smokers, phenotypic normal smokers, smokers with COPD and early COPD |
|
|
|
✓ |
|
|
|
|
| ||||
|
Chng_Multiple |
Expression data from different stages of plasma cell neoplasm. |
|
✓ |
|
✓ |
|
|
|
|
| ||||
|
Creighton_Prostate |
Genomic
profiling of prostate |
|
|
|
✓ |
|
|
✓ |
|
| ||||
|
DeJager_Multiple |
Expression data from relapsing/remitting MS samples |
|
|
|
✓ |
|
|
|
|
| ||||
|
Diette_Asthma_ |
PGA human CD4+ lymphocytes. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Finelt_OncostatinM_ |
Oncostatin experiment |
|
|
|
✓ |
|
|
|
|
| ||||
|
Fitsialos_Wounded |
Transcriptional signature of |
|
|
|
✓ |
|
|
|
|
| ||||
|
Gandhi_Multiple |
Multiple Sclerosis Blood Cell mRNA Transcriptome |
|
|
|
✓ |
|
|
|
|
| ||||
|
Goertsches_Multiple |
Expression data of multiple sclerosis patients receiving Interferon-beta therapy |
|
|
|
✓ |
|
|
|
|
| ||||
|
Gurevich_Multiple |
Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells |
|
|
|
✓ |
|
|
|
|
| ||||
|
Hecker_Multiple |
Expression data of multiple sclerosis patients receiving Interferon-beta therapy |
|
|
|
✓ |
|
|
|
|
| ||||
|
Kaminski_IPF_ |
MMP1 and MMP7 as potential peripheral blood biomarkers in Idiopathic Pulmonary Fibrosis |
|
|
|
✓ |
|
|
|
|
| ||||
|
Kato_NHLymphoma_ |
SNP data from lymphoma samples |
|
|
|
|
|
|
✓ |
|
| ||||
|
Khambata-Ford_ |
Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
|
✓ |
|
✓ |
|
|
|
|
| ||||
|
Lilly_Asthma_GSE3004 |
Effects of allergen challenge on airway epithelial cell gene expression. Transcription profiling of human airway epithelial cells before and after segmental allergen challenge to identify effects of allergen challenge on airway epithelial cell gene expression |
|
|
|
✓ |
|
|
|
|
| ||||
|
Lindsey_Multiple |
Gene expression changes in multiple sclerosis relapse suggest activation of T and non-T cells |
|
|
|
✓ |
|
|
|
|
| ||||
|
Lu_ColorectalCancer |
Affymetrix SNP array data for NSCLC and CRC |
|
|
|
|
|
|
✓ |
|
| ||||
|
Malhotra_Multiple |
Search for specific biomarkers of IFN-beta bioactivity in patients with MS |
|
|
|
✓ |
|
|
|
|
| ||||
|
Milano_Scleroderma_ |
Gene Expression Profiling of Scleroderma Skin |
|
|
|
✓ |
|
|
|
|
| ||||
|
Misior_Asthma_ |
Effects of glucocorticoids and Protein Kinase A on growth factor- and 1beta- regulated gene |
|
|
|
✓ |
|
|
|
|
| ||||
|
Mulligan_Multiple |
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib |
|
✓ |
|
✓ |
|
|
|
|
| ||||
|
Nevins_LungCancer_ |
Signatures of Oncogenic Pathway Deregulation in Human Cancers |
|
|
|
✓ |
|
|
|
|
| ||||
|
Radom_Azik_Exercise_GSE8668 |
Effects of exercise on gene expression in human neutrophils |
|
|
|
✓ |
|
|
|
|
| ||||
|
Ramakrishna_OvarianCancer_GSE19539 |
Identification of Novel Oncogene Loci in Ovarian Cancer through Integrated Copy Number and Expression Analysis |
|
|
|
|
|
|
✓ |
|
| ||||
|
Raponi_Acute_ |
A two-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Raponi_Squamous |
Gene expression signatures for predicting prognosis of squamous cell lung carcinomas. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Reid_ColorectalCancer_GSE16125 |
Prioritizing cancer genes in sporadic colon cancer |
|
|
|
|
|
|
✓ |
|
| ||||
|
Riker_Melanoma_ |
Gene expression patterns involved in the malignant transformation and progression of metastatic melanoma. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Rosenbaum_ |
Gene expression in inflammatory diseases. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Sboner_Prostate |
Molecular Sampling of Prostate Cancer: a dilemma for predicting disease progression |
|
|
|
✓ |
|
|
|
|
| ||||
|
Scatolini_Melanoma_ |
Melanoma: comparison between common nevi, radial/vertical growth phase melanoma, metastases and dysplastic nevi |
|
|
|
✓ |
|
|
|
|
| ||||
|
Shaughnessy_ |
Gene expression profiles of multiple myeloma |
|
|
|
✓ |
|
|
|
|
| ||||
|
Shaykhiev_COPD_ |
Smoking-dependent Reprogramming of Alveolar Macrophage Polarization: Implication for Pathogenesis of COPD |
|
|
|
✓ |
|
|
|
|
| ||||
|
Sieber_Colorectal |
Expression data from primary colorectal cancers |
|
|
|
✓ |
|
|
|
|
| ||||
|
Sieber_Colorectal |
Expression data from 290 primary colorectal cancers |
|
|
|
✓ |
|
|
|
|
| ||||
|
Smith_Colorectal |
Metastasis Gene Expression Profile Predicts Recurrence and Death in Colon Cancer Patients. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Smith_KeloidFibrosis_GSE7890 |
Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways |
|
|
|
✓ |
|
|
|
|
| ||||
|
Spannhake_Asthma_ |
Asthma exacerbatory factors. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Spira_Smoking |
Effects of cigarette smoke on the human airway epithelial cell transcriptome. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Valk_AcuteMyeloid |
Expression profiles of acute myeloid leukemia patient samples. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Wang_Breast |
Breast cancer relapse free survival |
|
|
|
✓ |
|
|
|
|
| ||||
|
Wang_TransBIG_ |
Strong time dependence of the 76-gene prognostic signature. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Watanabe_Colorectal |
Gene expression signature of colorectal cancer with microsatellite instability |
|
|
|
✓ |
|
|
|
|
| ||||
|
Watson_Lung |
Discovery of somatic mutations in lung adenocarcinomas |
|
|
|
✓ |
|
|
|
|
| ||||
|
Woodruff_Asthma_ |
A distinctive alveolar macrophage activation state induced by cigarette smoking. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Woodruff_Asthma_ |
Genome-Wide Profiling of Airway Epithelial Cells in Asthmatics, Smokers and Healthy Controls |
|
|
|
✓ |
|
|
|
|
| ||||
|
Yu_AcuteMyeloid |
Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory AML. |
|
|
|
✓ |
|
|
|
|
| ||||
|
Zaba_Psoriasis_ |
Gene expression profiles as response to etanercept treatment in patients with Psoriasis. |
|
|
|
✓ |
|
|
|
|
| ||||